CIK 0001690585
- Non-accelerated filer
- Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,717,056
- in 3 filings, $15.7M under 10b5-1 plans
Net −$15,717,056. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Soteropoulos Paula Director | Grant or award · Stock Option (Right to Buy) | +6,090 | 6,090 | ||
| 2026-05-08 | Soteropoulos Paula Director | Exercise or conversion 10b5-1 | +599 | $8.44 | $5K | 599 |
| 2026-05-08 | Soteropoulos Paula Director | Sale 10b5-1 | −599 | $85.47 | $51K | 0 |
| 2026-05-08 | Soteropoulos Paula Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −599 | 0 | ||
| 2026-03-31 | Soteropoulos Paula Director | Exercise or conversion 10b5-1 | +599 | $8.44 | $5K | 599 |
| 2026-03-31 | Soteropoulos Paula Director | Sale 10b5-1 | −599 | $80.11 | $48K | 0 |
| 2026-03-31 | Soteropoulos Paula Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −599 | 599 | ||
| 2026-03-24 | Soteropoulos Paula Director | Exercise or conversion 10b5-1 | +27,594 | $8.44 | $233K | 27,594 |
| 2026-03-24 | Soteropoulos Paula Director | Sale 10b5-1 | −27,594 | $78.05 | $2.2M | 0 |
| 2026-03-24 | Soteropoulos Paula Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −27,594 | 1,198 | ||
| 2025-05-22 | Soteropoulos Paula Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-05-23 | Soteropoulos Paula Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2023-09-11 | Soteropoulos Paula Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 |
Page 1 of 1 · 13 trades